a Department of Pharmaceutics and Pharmaceutical Technology, Institute of Pharmacy , Nirma University , Ahmedabad , India.
b Pharmaceutical Technology Centre , Cadila Healthcare Limited , Ahmedabad , India.
Expert Opin Drug Deliv. 2018 Apr;15(4):351-368. doi: 10.1080/17425247.2018.1444025. Epub 2018 Mar 1.
Skin is an important route of drug delivery for the treatment of various dermatological conditions. The advent of nanotechnology is paving the roadmaps for topical drug delivery by providing sustained release as well as maintaining a localized effect, outweighing the toxicity concern.
This review highlighted the morphology of skin, its barrier nature as well as drug penetration pathways after topical application of formulations. The existing methods to improve topical drug delivery, by infringing or permeating the skin barriers, are discussed. This context concretes the foundation to accentuate the need for the development of nanocrystal-based topical formulation. The mechanism of drug release, immediate as well as sustained release, after topical administration of drug nanocrystals is also elaborated. The special emphasis is given on the breakthrough achieved, in topical drug delivery using drug nanocrystals, so far in the plethora of literature, patents, and products, under clinical trial as well as in the market.
The current research on nanocrystals for topical drug delivery is highlighting the breakthroughs achieved so far. The output of these research envisages that topical nanocrystals based formulations can be a novel strategy for the drugs which are facing solubility, bioavailability and toxicity concerns.
皮肤是治疗各种皮肤病的重要药物输送途径。纳米技术的出现为局部药物输送铺平了道路,提供了持续释放以及维持局部效果,从而克服了毒性问题。
本文强调了皮肤的形态、其屏障特性以及制剂经皮给药后的药物渗透途径。讨论了通过侵犯或渗透皮肤屏障来改善局部药物输送的现有方法。这种情况具体说明了需要开发基于纳米晶体的局部制剂的基础。还阐述了药物纳米晶体经皮给药后立即和持续释放的药物释放机制。特别强调了在药物纳米晶体的局部药物输送中取得的突破,这在众多文献、专利和产品中,包括临床试验中和市场上的产品。
目前关于纳米晶体用于局部药物输送的研究强调了迄今为止取得的突破。这些研究的成果表明,基于纳米晶体的局部制剂可能是解决药物溶解度、生物利用度和毒性问题的新策略。